Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Gossamer Bio (GOSS)
at www.tipranks.com (Mon, 27-Jul 1:10 PM)
Outlook Therapeutics Gains FDA Approval for LYTENAVA Launch
at www.tipranks.com (Fri, 24-Jul 5:32 PM)
Outlook gains approval for ophthalmic bevacizumab for wet AMD
at seekingalpha.com (Fri, 24-Jul 3:20 PM)
Outlook Therapeutics Grants Incentive Awards Tied to FDA Approval
at www.tipranks.com (Fri, 24-Jul 6:39 AM)
Market Chameleon (Tue, 16-Jun 11:06 AM)
FDA Appeal Win Clears Path for Outlook Therapeutics' LYTENAVA—Resubmission Expected Next Month
Market Chameleon (Wed, 27-May 10:33 AM)
FDA Appeal Win Clears Path for Outlook Therapeutics' ONS-5010/LYTENAVA to Resubmit for Approval
Market Chameleon (Tue, 26-May 9:52 AM)
